Friday, September 27, 2019

Millennials Continue to Leave Big Cities - WSJ

Millennials Continue to Leave Big Cities - WSJ



...Large U.S. cities lost tens of thousands of millennial and younger Gen X residents last year, according to Census figures released Thursday that offer fresh signs of cooling urban growth.

Wednesday, September 25, 2019

How Greta Thunberg's rise could backfire on environmentalists

How Greta Thunberg's rise could backfire on environmentalists



...In a remarkable interview on PBS last week, author Jonathan Safran Foer spoke out against Warren’s comments and pointed out that those who say they believe in the dire effects of climate change would do more than protest if they really believed it. That point is the premise of Foer’s new book, “We Are the Weather: Saving the Planet Begins at Breakfast.”





...If the activists protesting right now could get the most serious climate change threats eliminated, but without politically defeating President Trump and Republicans and/or putting the big oil companies out of business in the process, would they still be interested in the cause?

Sunny Portugal: A gateway to Europe's medical pot market - Reuters

Sunny Portugal: A gateway to Europe's medical pot market - Reuters



Sunny Portugal: A gateway to Europe's medical pot market

CANTANHEDE, Portugal (Reuters) - Famous for its roasted suckling pig and wines, the Portuguese city of Cantanhede now hosts the country’s first medical cannabis production farm - a budding European hub of efforts to meet growing demand for the flowering herb.
Cannabis plants grow inside the Tilray factory hothouse in Cantanhede, Portugal April 24, 2019. REUTERS/Rafael Marchante
Portugal’s California-like weather caught the eye of Canada-based Tilray as its CEO Brendan Kennedy roved around Europe from 2015 to 2017 in search of the perfect spot for a new production site.
Kennedy said Portugal had the ideal climate for cannabis cultivation and the country’s young, educated workforce and its major agricultural sector were further attractions.
Covering 2.4 hectares (5.9 acres) in a biotechnology park just outside Cantanhede, Tilray’s site was given the green light by Portugal’s regulator Infarmed in 2017. The company then rushed to import its first baby plants and recently reported its first two successful cannabis harvests.Kennedy opened the site to visitors for the first time at a ribbon-cutting ceremony on Wednesday.
“Some of our competitors are located in Denmark and northern Germany, where there isn’t that much sun - so we think we can produce a more environmentally-friendly product here,” he told Reuters.
Portugal also offers tariff-free entry to the rest of the European Union, a market Tilray wants to explore further at a time when an increasing number of governments are legalising medical marijuana.

FROM PROHIBITION TO LEGALISATION

“The paradigm is shifting from prohibition to legalisation,” Kennedy said, with demand for the product growing. “I’m fairly optimistic that over the next two years we will see every country in Europe legalising it.”
Last year Portugal’s parliament approved a bill to legalise marijuana-based medicines, following in the footsteps of EU countries such as Italy and Germany as well as Canada and parts of the United States. Britain made a similar move in July 2018.
Tilray’s 20-million-euro (17.27 million pounds) facility includes indoor, outdoor and greenhouse cultivation sites, as well as research labs, processing, packaging and distribution sites for medical cannabis and cannabinoid-derived products.
Tilray supplies medical cannabis products with CBD and THC to patients in a number of countries, through subsidiaries in Australia, Canada, Germany and Latin American, and through agreements with pharmaceutical distributors.
Earlier this year, the European Parliament called for an EU-wide policy on medical cannabis and properly funded scientific research.
“We are at point where almost every doctor around the world recognises the medical benefits of cannabis,” Kennedy said.
The World Health Organization has stated that several studies have demonstrated cannabinoids provide therapeutic effects for nausea and vomiting in the advanced stages of illnesses such as cancer and AIDS.
Moreover, a handful of regulated pharmaceuticals use chemicals derived from cannabis, such as GW Pharmaceuticals’ Sativex which is approved for treating symptoms of multiple sclerosis.

Tuesday, September 24, 2019

BMW helped design this hydrogen-powered flying thing | Top Gear

BMW helped design this hydrogen-powered flying thing | Top Gear

The climate theory casting new light on the history of Chinese civilisation | South China Morning Post

The climate theory casting new light on the history of Chinese civilisation | South China Morning Post



...Human societies have gone through temperature cycles such as the Medieval Warm Period (900- 1300) and Little Ice Age (1300-1870) Liu said, but most of that data came from Europe, not China.

The study left one big question. “Why do the sun’s activities vary every 500 years? Nobody can explain,” he said.

Monday, September 23, 2019

Ginkgo Bioworks Raises $290M for cell programming tech, brings total to $719M; Multi-Slide Guide to Carbon Capture - btbirkett@gmail.com - Gmail



Synthetic biology. It sounds like something from a sci-fi movie, or an oxymoron like jumbo shrimp or clearly confused. After all, biology is the study of living organisms. And synthetic means made by chemical synthesis, especially to imitate a natural product. But synthetic biology has real potential to replace costly or unsustainable manufacturing processes and solve pressing global challenges, and Ginkgo Bioworks is on it.

We got wind that Massachusetts-based Ginkgo Bioworks, referred to as "the organism company," that is using advanced biotechnology to grow products instead of manufacturing them, got a Series E financing round of $290 million bringing the company's total funding to $719 million . You got that right, $719 million total. 

Crash Course | The New Republic

Crash Course | The New Republic



...In the now infamous debacle of the Boeing 737 MAX, the company produced a plane outfitted with a half-assed bit of software programmed to override all pilot input and nosedive when a little vane on the side of the fuselage told it the nose was pitching up. The vane was also not terribly reliable, possibly due to assembly line lapses reported by a whistle-blower, and when the plane processed the bad data it received, it promptly dove into the sea.